These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11786552)

  • 1. Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.
    Schneider M; Nagashima M; Knappe S; Zhao L; Morser J; Nesheim M
    J Biol Chem; 2002 Mar; 277(12):9944-51. PubMed ID: 11786552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.
    Wu C; Kim PY; Manuel R; Seto M; Whitlow M; Nagashima M; Morser J; Gils A; Declerck P; Nesheim ME
    J Biol Chem; 2009 Mar; 284(11):7059-67. PubMed ID: 19074424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT; Boffa MB
    J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential.
    Wu C; Stafford AR; Fredenburgh JC; Weitz JI; Gils A; Declerck PJ; Kim PY
    Thromb Haemost; 2017 Jul; 117(8):1509-1517. PubMed ID: 28640323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for arginine-12 in thrombin-thrombomodulin-mediated activation of thrombin-activatable fibrinolysis inhibitor.
    Plug T; Kramer G; Meijers JC
    J Thromb Haemost; 2014 Oct; 12(10):1717-25. PubMed ID: 25066897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
    Schneider M; Boffa M; Stewart R; Rahman M; Koschinsky M; Nesheim M
    J Biol Chem; 2002 Jan; 277(2):1021-30. PubMed ID: 11684677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation.
    Wang W; Nagashima M; Schneider M; Morser J; Nesheim M
    J Biol Chem; 2000 Jul; 275(30):22942-7. PubMed ID: 10801821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor.
    Marx PF; Havik SR; Marquart JA; Bouma BN; Meijers JC
    J Biol Chem; 2004 Feb; 279(8):6620-8. PubMed ID: 14660622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells.
    Wu C; Kim PY; Swystun LL; Liaw PC; Weitz JI
    J Thromb Haemost; 2016 Feb; 14(2):366-74. PubMed ID: 26663133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the substrate binding site of thrombin-activatable fibrinolysis inhibitor (TAFI) alter its substrate specificity.
    Zhao L; Buckman B; Seto M; Morser J; Nagashima M
    J Biol Chem; 2003 Aug; 278(34):32359-66. PubMed ID: 12799375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
    Boffa MB; Wang W; Bajzar L; Nesheim ME
    J Biol Chem; 1998 Jan; 273(4):2127-35. PubMed ID: 9442053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin Glu-39 restricts the P'3 specificity to nonacidic residues.
    Le Bonniec BF; MacGillivray RT; Esmon CT
    J Biol Chem; 1991 Jul; 266(21):13796-803. PubMed ID: 1856211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.
    Kokame K; Zheng X; Sadler JE
    J Biol Chem; 1998 May; 273(20):12135-9. PubMed ID: 9575159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T; Marquart JA; Marx PF; Meijers JC
    J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains.
    Hall SW; Nagashima M; Zhao L; Morser J; Leung LL
    J Biol Chem; 1999 Sep; 274(36):25510-6. PubMed ID: 10464282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation.
    Zhou X; Declerck PJ
    J Thromb Haemost; 2015 Jun; 13(6):1084-9. PubMed ID: 25773535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
    J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
    Bajzar L; Nesheim M; Morser J; Tracy PB
    J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of stable TAFIa variants: importance of alpha-helix 9 and beta-sheet 11 for TAFIa (in)stability.
    Ceresa E; De Maeyer M; Jonckheer A; Peeters M; Engelborghs Y; Declerck PJ; Gils A
    J Thromb Haemost; 2007 Oct; 5(10):2105-12. PubMed ID: 17666015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
    van Moorsel MVA; Poolen GC; Koekman CA; Verhoef S; de Maat S; Barendrecht A; van Kleef ND; Meijers JCM; Schiffelers RM; Maas C; Urbanus RT
    J Thromb Haemost; 2022 May; 20(5):1213-1222. PubMed ID: 35170225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.